FICI, PIETRO
FICI, PIETRO
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
2022 Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G.
Single-cell NGS-based analysis of copy number alterations reveals new insights in circulating tumor cells persistence in early-stage breast cancer
2020 Rossi T.; Gallerani G.; Angeli D.; Cocchi C.; Bandini E.; Fici P.; Gaudio M.; Martinelli G.; Rocca A.; Maltoni R.; Fabbri F.
Crowdfunding for cancer research: the TRACe campaign as an example
2019 Gallerani G.; Fici P.; Coatti A.; Mariotti P.; Passeri F.; Battistelli L.
Circulating tumor cells: Back to the future
2017 Gallerani G.; Fici P.; Fabbri F.
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
2017 Fici P.; Gallerani G.; Morel A.-P.; Mercatali L.; Ibrahim T.; Scarpi E.; Amadori D.; Puisieux A.; Rigaud M.; Fabbri F.
CTCs in early breast cancer: A path worth taking
2016 Maltoni R.; Gallerani G.; Fici P.; Rocca A.; Fabbri F.
Circulating tumor cells in early breast cancer: A connection with vascular invasion
2015 Maltoni R.; Fici P.; Amadori D.; Gallerani G.; Cocchi C.; Zoli M.; Rocca A.; Cecconetto L.; Folli S.; Scarpi E.; Serra P.; Fabbri F.
Epithelial Mesenchymal Transition: a double-edged sword
2015 Guislaine Barriere, Pietro Fici, Giulia Gallerani, Francesco Fabbri, Michel Rigaud
Circulating tumor cells and epithelial, mesenchymal and stemness markers: Characterization of cell subpopulations
2014 Barriere G.; Fici P.; Gallerani G.; Fabbri F.; Zoli W.; Rigaud M.
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
2013 Fabbri F.; Carloni S.; Zoli W.; Ulivi P.; Gallerani G.; Fici P.; Chiadini E.; Passardi A.; Frassineti G.L.; Ragazzini A.; Amadori D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis | Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinell...i G.; Fabbri F.; Gallerani G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03925-v2.pdf; cancers-14-03925-s001.zip |
| Single-cell NGS-based analysis of copy number alterations reveals new insights in circulating tumor cells persistence in early-stage breast cancer | Rossi T.; Gallerani G.; Angeli D.; Cocchi C.; Bandini E.; Fici P.; Gaudio M.; Martinelli G.; Rocc...a A.; Maltoni R.; Fabbri F. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-02490-v2.pdf; cancers-12-02490-s001.zip |
| Crowdfunding for cancer research: the TRACe campaign as an example | Gallerani G.; Fici P.; Coatti A.; Mariotti P.; Passeri F.; Battistelli L. | 2019-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Circulating tumor cells: Back to the future | Gallerani G.; Fici P.; Fabbri F. | 2017-01-01 | FRONTIERS IN ONCOLOGY | - | 1.03 Recensione in rivista | - |
| Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer | Fici P.; Gallerani G.; Morel A.-P.; Mercatali L.; Ibrahim T.; Scarpi E.; Amadori D.; Puisieux A.;... Rigaud M.; Fabbri F. | 2017-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| CTCs in early breast cancer: A path worth taking | Maltoni R.; Gallerani G.; Fici P.; Rocca A.; Fabbri F. | 2016-01-01 | CANCER LETTERS | - | 1.03 Recensione in rivista | - |
| Circulating tumor cells in early breast cancer: A connection with vascular invasion | Maltoni R.; Fici P.; Amadori D.; Gallerani G.; Cocchi C.; Zoli M.; Rocca A.; Cecconetto L.; Folli... S.; Scarpi E.; Serra P.; Fabbri F. | 2015-01-01 | CANCER LETTERS | - | 1.01 Articolo in rivista | - |
| Epithelial Mesenchymal Transition: a double-edged sword | Guislaine Barriere, Pietro Fici, Giulia Gallerani, Francesco Fabbri, Michel Rigaud | 2015-01-01 | CLINICAL AND TRANSLATIONAL MEDICINE | - | 1.03 Recensione in rivista | - |
| Circulating tumor cells and epithelial, mesenchymal and stemness markers: Characterization of cell subpopulations | Barriere G.; Fici P.; Gallerani G.; Fabbri F.; Zoli W.; Rigaud M. | 2014-01-01 | ANNALS OF TRANSLATIONAL MEDICINE | - | 1.03 Recensione in rivista | - |
| Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs | Fabbri F.; Carloni S.; Zoli W.; Ulivi P.; Gallerani G.; Fici P.; Chiadini E.; Passardi A.; Frassi...neti G.L.; Ragazzini A.; Amadori D. | 2013-01-01 | CANCER LETTERS | - | 1.01 Articolo in rivista | - |